Design of randomized trials

Epidemiologic Reviews

Volumn 24, Issue 1, 2002, Pages 4-11

  Green, Sylvan B ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; FACTORIAL ANALYSIS; FOLLOW UP; HUMAN; MASKING; OUTCOMES RESEARCH; POPULATION RISK; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EPIDEMIOLOGY; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICS;

BIAS (EPIDEMIOLOGY); DOUBLE-BLIND METHOD; HUMAN; RANDOMIZED CONTROLLED TRIALS; SAMPLE SIZE; HUMANS;

EID: 0036019104     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/epirev/24.1.4     Document Type: Review

References (34)

1. Hypothesis testing in clinical trials
2. Clinical trials in cancer
3. Randomized clinical trials: Perspectives on some recent ideas
4. Patient heterogeneity and the need for randomized clinical trials
5. Using observational data from registries to compare treatments: The fallacy of omnimetrics
6. Randomised controlled trials in cardiovascular medicine: Past achievements, future challenges
7. Approaches to monitoring the results of long term disease prevention trials: Examples from the Women's Health Initiative
8. Analysis of randomized controlled trials
9. Large-scale randomized evidence: Large, simple trials and overviews of trials
10. Sample size calculations for randomized controlled trials
11. Special issues related to randomized trials of primary prevention
12. Assessing apparent treatment-covariate interactions in randomized clinical trials
13. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials
14. Statistical designs for investigating several interventions in the same study: Methods for cancer prevention trials
15. Cost and efficiency in clinical trials: The US Physicians' Health Study
16. Final report on the aspirin component of the ongoing Physicians' Health Study
17. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
18. Design of the Women's Health Initiative clinical trial and observational study
19. The Women's Health Initiative: Recruitment complete-looking back and looking forward
20. Estimating the effect of the run-in on the power of the Physicians' Health Study
21. Design of the Prostate Cancer Prevention Trial (PCPT)
22. Statistical considerations in the intent-to-treat principle
23. Randomization by group: A formal analysis
24. Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization
25. Impact of vitamin A supplementation on childhood mortality: A randomized controlled community trial
26. Impact of vitamin A supplementation on xerophthalmia: A randomized controlled community trial
27. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomized controlled trial
28. A community trial of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design
29. Community Intervention Trial for Smoking Cessation (COMMIT): 1. Cohort results from a four-year community intervention
30. Community Intervention Trial for Smoking Cessation (COMMIT): 2. Changes in adult cigarette smoking prevalence
31. A dietary intervention in primary care practice: The Eating Patterns Study